Pranaya Pharmaceuticals Private Limited logo

Pranaya Pharmaceuticals Private Limited

Develops and sells a range of pharmaceutical products, including amantadine, brimonidine, dobutamine, amisulpride, and cetirizine.
2020 | Hyderabad, Telangana (India) | Active

Last Updated:

December 11, 2024
HomeCompanyPranaya Pharmaceuticals Private Limited

Who are the key members and board of directors at Pranaya Pharmaceuticals?

Board Members(5)

NameDesignationAppointment DateStatus
Sanagala Reddy In Director 17-Mar-2020Current
Govinda Balineni In Additional Director 14-Feb-2022Current
Kanigiri Gade In Director 22-Apr-2020Current
Balineni Aruna In Additional Director 14-Feb-2022Current
Kumaraswamy Maruri In Additional Director 22-May-2023Current

Financial Performance of Pranaya Pharmaceuticals.

Pranaya Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
Revenue from Operations
Total Assets
Profit or Loss
Net Worth
EBITDA

Related Corporates (Common Directorship)

Charges (Loans)

Open Charges

₹18.75 Cr

LenderAmountStatus

Indian Bank

Creation Date: 08 Nov 2021
₹18.75 CrOpen

How Many Employees Work at Pranaya Pharmaceuticals?

Unlock and access historical data on people associated with Pranaya Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Pranaya Pharmaceuticals

Recent activity within the organization

  • Director Appointment

    Kumaraswamy Reddy Maruri was appointed as a Additional Director was appointed as a Additional Director on 22 May 2023 & has been associated with this company since 1 year 7 months .

    22 May 2023

  • Annual General Meeting

    Pranaya Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records.

    30 Sep 2022

  • Balance Sheet

    Pranaya Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad.

    31 Mar 2022

  • Director Appointment

    Govinda Reddy Balineni was appointed as a Additional Director was appointed as a Additional Director on 14 Feb 2022 & has been associated with this company since 2 years 10 months .

    14 Feb 2022

  • Director Appointment

    Balineni Aruna was appointed as a Additional Director was appointed as a Additional Director on 14 Feb 2022 & has been associated with this company since 2 years 10 months .

    14 Feb 2022

  • Charges

    A charge with Indian Bank amounted to Rs. 18.75 Cr with Charge ID 100501338 was registered on 08 Nov 2021.

    08 Nov 2021

Frequently asked questions

  • Pranaya Pharmaceuticals Private Limited was incorporated on 17 Mar 2020.

  • The authorized share capital of Pranaya Pharmaceuticals Private Limited is ₹ 3.00 Cr and paid-up capital is ₹ 1.00 Cr.

  • Currently 5 directors are associated with Pranaya Pharmaceuticals Private Limited.

    • Sanagala Sridhar Reddy
    • Govinda Reddy Balineni
    • Kanigiri Gade
    • Balineni Aruna
    • Kumaraswamy Reddy Maruri
  • As per Ministry of Corporate Affairs (Mca), the registered address of Pranaya Pharmaceuticals Private Limited is Plot No 43 Sy No.55To58 5Th Floor, The Park View Behind Preston Prime Mall Lumbini Avenue Hyderabad India, Gachibowli, Telangana, 500032.

  • The corporate identification number (CIN) of Pranaya Pharmaceuticals Private Limited is U24239TG2020PTC139841 and the company number is 139841 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Pranaya Pharmaceuticals Private Limited is https://www.pranayagroup.com

  • As per the financial statements for fiscal Year 2022, The total open charges for Pranaya Pharmaceuticals Private Limited amount to ₹ 18.75 Cr.

  • The most recent Balance Sheet for Pranaya Pharmaceuticals Private Limited was filed with the ROC on 31 Mar 2022.

People also Viewed

Similar Companies Based on Drug Formulation & Development